For research use only. Not for therapeutic Use.
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1].
| Catalog Number | I042409 |
| CAS Number | 595566-61-3 |
| Purity | ≥95% |
| Reference | [1]. Weisman LE, et, al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128(2):271-9. |
